Cancer BiologybioRxivPreprint
Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins
Galen C. Rask, Cenny Taslim, Ariunaa Bayanjargal…·Emily R. Theisen
This study shows seclidemstat inhibits the transcriptional activity of multiple FET fusion oncoproteins in vitro, suggesting it as a promising treatment for FET-rearranged sarcomas.
3 citations